Protein That Calms Waking Hair Follicles Could Lead to Alopecia Treatment
A new study has identified a protein that appears to be essential for hair growth and hair follicle protection. Called MCL‑1, it could potentially be targeted by treatments for certain kinds of baldness such as alopecia.
Led by a team from the Duke‑NUS Medical School in Singapore and the Walter and Eliza Hall Institute of Medical Research in Australia, researchers found that when MCL-1 production was blocked in mice, the animals lost their hair later in life.
Hair follicles go through cycles of quiescence and growth, with MCL-1 playing a critical role in the latter phase. The protein doesn't seem to affect the resting phase or the initial development of hair follicles, however.
"Acute MCL‑1 deletion rapidly depletes activated hair follicle stem cells and completely blocks depilation‑induced hair regeneration in adult mice, while quiescent hair follicle stem cells remain unaffected," write the researchers in their published paper.
It was already known that MCL-1 played an important role in protecting a number of different kinds of tissue from apoptosis; the programmed death of redundant or damaged cells to keep the body functioning.
When it comes to hair, MCL-1 prevents follicle stem cells from being stressed and damaged as they 'reawaken' from rest. Without MCL-1 to protect them, these cells stop functioning.
The team was also able to reveal new details on MCL-1's function, identifying ways it suppresses another protein called BAK and how MCL-1 is regulated by a signaling pathway called ERBB. These details could be useful in developing new methods of hair loss treatments.
"These findings suggest that ERBB signaling modulates MCL‑1 expression through translational control mechanisms, particularly during periods of heightened apoptosis and regression in the hair cycle," the researchers write.
The study was based solely on mice, so while there's good reason to think the same processes are happening on the top of our own heads, the findings will need to be replicated in clinical research on humans.
It's also worth bearing in mind that there are several different kinds of alopecia, all with a variety of contributing causes: if treatments are one day developed that focus on boosting MCL-1, they're not going to work for all types of hair loss.
Those limitations aside, this one protein's handiwork is a significant revelation concerning hair follicles' ability to grow hair. The findings could also inform future studies into other processes affected by MCL-1, including cancer cell death.
"This study advances our understanding of the molecular mechanisms underlying hair follicle regeneration and offers new insights into how stem cell survival and tissue regeneration are orchestrated," write the researchers.
"These findings may have broader implications for controlling the survival of stem and progenitor cells in tissue regeneration and cancer expansion."
The research has been published in Nature Communications.
Woman's Brain Implant Turns Her Thoughts Into Speech in Real Time
Sometimes Alzheimer's Strikes Early. This Experimental Drug May Help.
Dangerous Fungal Infection Sees a Dramatic Increase in US Hospitals
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
20 hours ago
- The Hill
Beyond MAHA: Defeating obesity requires a new strategy
Obesity is a major health problem facing our country. According to the CDC, more than 40 percent of the U.S. population is obese, defined as having a body-mass index above 30. As astounding at that number is, it is perhaps even more surprising that nearly 20 percent of children in the U.S. are obese. Obesity leads to significant health challenges, including diabetes, stroke, cardiovascular disease and liver disease. It is clear that as a nation we must face this crisis on multiple fronts. Diet and exercise certainly help, and it's critical to ensure that people of all socioeconomic backgrounds have access to healthy foods (free of preservatives, unnecessary dyes, high fructose corn syrups etc.) and are educated in making healthy lifestyle choices. The MAHA or 'Make America Healthy Again' movement has highlighted this as one of its key objectives, and if it is successful, we should see an impact on obesity — especially in children, where diet and exercise have a huge impact on weight-related health outcomes. Obesity in adults, however, is often more challenging. Many adults with obesity struggle to lose weight, despite considerable efforts to modify their lifestyle through diet and exercise. This is because our metabolism changes as we age, and many adults who are overweight develop metabolic dysfunction or 'metabolic syndrome,' which then further perpetuates weight gain and exacerbates the situation. It has become clear in recent years that many people struggling with obesity require medical intervention – not just lifestyle intervention – and that prescriptions can substantially improve weight loss. The explosion in use of GLP-1 agonists, such as Wegovy and Zepbound, over the last two years has underscored the need for medical intervention in obese and overweight patients. Currently, about 6 percent of the U.S. population, or 15 million people, are on GLP-1 weight loss treatments, and the numbers are only expected to increase. However, while most patients lose 10 percent to 25 percent of their body weight while on a GLP-1, they do not maintain GLP-1 treatment in the long-term, with approximately 80 percent of patients discontinuing treatment within 1 year. Gastrointestinal side effects, injectable administration, and high cost have prevented long-term use of GLP-1's for weight maintenance. And unfortunately, most patients gain back all the weight after stopping the medication. Healthcare professionals and the pharmaceutical industry now recognize that obesity — like most other medical conditions — requires an 'arsenal' of treatments, rather than a one-size-fits-all approach. Post-GLP-1 weight maintenance is now widely recognized as an emerging unmet need. And patients who are not candidates for or cannot tolerate GLP-1s require alternatives. Diet and lifestyle modifications are important alongside prescription medications in fighting obesity. If we are going to be successful in overcoming this major health crisis, we need to ensure that both the pharmaceutical industry and groups like MAHA work hand in hand. Both treatment and prevention are critical in order to regain control of our nation's health. Dr. Shoshana Shendelman, Ph.D. is a scientist and entrepreneur who has founded numerous biotech companies. She is a pioneer in the development of drugs and therapeutics for rare and underserved diseases. Currently she is Vice Chair of the Advisory Board of Columbia University Medical Center and Columbia University Vagelos College of Physicians and Surgeons.
New York Post
2 days ago
- New York Post
Weight loss drugs like Ozempic could mess with your birth control — and get you pregnant
A UK watchdog is urging women on GLP-1 weight-loss drugs like Ozempic and Mounjaro to use effective forms of birth control after receiving more than 40 pregnancy-related reports linked to the medications. The warning comes as women flood social media with stories of their so-called 'Ozempic babies' — including surprise pregnancies while on the pill. Trying to shed pounds, not grow a baby bump? Here's what you need to know about GLP-1s, pregnancy and the best contraception options to stay protected. 4 Studies show that at least one in eight US adults have tried GLP-1s. íÅí°íâ¬í¸í½í° íâíµí¼íµíËí°í¾ – What's in your GLP-1? Several GLP-1 drugs dominate the market, including Ozempic and Wegovy. Both contain semaglutide, an active ingredient that mimics a natural hormone in the body that boosts insulin production, slows digestion and curbs appetite. Then there's Saxenda and Victoza, powered by liraglutide, which functions in a similar way. Newer drugs like Mounjaro and Zepbound rely on tirzepatide, a key ingredient that targets a second hormone involved in appetite and blood sugar control. A surprise side effect While gastrointestinal symptoms like nausea, vomiting and diarrhea are common with GLP-1s, the surprise side effect making waves is unexpected pregnancy. The UK's Medicines and Healthcare Products Regulatory Agency (MHRA) has received 28 reports related to pregnancy in patients on tirzepatide, and nine each for semaglutide and liraglutide. 4 Women on tirzepatide-based GLP-1s should use barrier contraception. nenetus – In an alert this week, the agency warned that tirzepatide may reduce the effectiveness of oral contraceptives, especially in women with higher body weight. As a result, it recommended using barrier methods like condoms while on drugs like Mounjaro. So far, there's no evidence that GLP-1s affect non-oral birth control like IUDs, implants, patches, or rings, according to the UK's Faculty of Reproductive Healthcare. And yes, the advice applies even to women previously told they were infertile. GLP-1s have been shown to boost fertility by aiding weight loss, reducing inflammation and improving insulin sensitivity — leading some to conceive just months after starting treatment. 4 GLP-1 agonists can increase your fertility, but they can also interfere with pregnancy. Louis-Photo – Can you take GLP-1s while pregnant? Experts say no — at least not yet. There's not enough data to confirm whether GLP-1s are safe during pregnancy. While a some human studies suggests there is no harm in first-trimester use, testing in animals has shown the drugs could increase the risk of miscarriage and birth defects. 4 Scientists are still working to understand whether GLP-1s can negatively impact a developing fetus. Evrymmnt – Another reason to skip GLP-1s while pregnant: they suppress your appetite and can trigger gastrointestinal issues, which may lead to nutrient deficiencies that impact fetal development. The drugs should also be avoided during breastfeeding, since there's not enough research to confirm safety for infants. Trying to conceive? Here's the timeline If you're planning to get pregnant, the MHRA recommended stopping GLP-1s before you start trying to conceive and giving your body time to clear the drugs. For semaglutide users, that means quitting at least two months ahead. If you're on tirzepatide, stop one month before trying. Liraglutide clears the system faster, so you can stop right before you start trying to conceive.
Business Insider
2 days ago
- Business Insider
Dairy is so back. It's now a high-protein, gut-healthy superfood shoppers love.
Want to snack on something that's high in protein, gut-friendly, minimally processed, and tastes good? Hit the dairy aisle. After years of being outshone and relegated to second best by shiny, new plant-based alternatives like oat milk and cashew cream, dairy is not only in demand, it's having a glow-up. Products like mint chocolate cookie probiotic ice cream and pistachio-flavored kefir — some of which come wrapped in whimsical, retro-style packaging — are hitting the market as dairy finds itself at the center of the Venn diagram of health, food, and cultural trends. "I really have not seen this type of dairy innovation in past years," Jessica Rubino of New Hope Network, an organic-focused consultancy firm that tracks US food and drink industry trends, told Business Insider. According to the organization's insights, the organic dairy sector grew by 9.8% in 2024, up from 5.6% the previous year — far higher than the one or two percent a year increase seen since around 2015. "That type of increase in growth is pretty significant," Rubino said. Dairy aligns with health trends With 82% of US consumers considering wellness a top or important priority in their everyday lives, according to 2024 trend data from McKinsey, food and drink can't just taste good, it needs to provide health benefits too. A large part of dairy's appeal right now is that it's high in protein and minimally processed. Whether you want to eat enough protein to build muscle, you use a GLP-1 and need more protein to maintain muscle mass or are a member of the manosphere following the carnivore diet, we've gone protein-crazy in recent years. The global protein market is estimated to reach over $47.4 billion by 2032, up from $26 billion in 2021, according to Statista. Protein-enhanced products, such as sodas, waters, powders, and bars, have taken over grocery store aisles. Fairlife, the industry leader in ultra-filtered milk, which contains 50% more protein than regular milk, has seen dollar sales rise by 31% in the past 12 months, according to data from market research agency Circana. The milk is filtered to separate its components (water, lactose, protein, fat, and vitamins and minerals) and reformulated. Lactose and sugar are removed, and protein is concentrated. Melissa Altobelli, a dairy industry analyst at Circana, told BI that Fairlife, which has been around since 2012, has exploded in popularity recently because its product chimes with current trends. "It's not that the effort wasn't made in the past. It's just more appealing to consumers currently," she said, adding: "Protein is in everything at this point, and that's what consumers are looking for." Rubino also sees gut health as a particularly big draw for dairy, as people seek out functional foods to "optimize" their health and live longer. "You can get high dosages of probiotics through these food products," she said. The ultra-processed foods backlash is good news for dairy As ultra-processed foods take over from carbs as the demon of the dietary world, shoppers are losing their appetite for them. Typically long-lasting and designed to be irresistible and easy to eat, these foods contain ingredients you wouldn't find in a regular kitchen, such as gums, emulsifiers, and colors. Mounting research links ultra-processed foods to a host of health conditions — from type 2 diabetes to depression and poor gut health. As public awareness of ultra-processed foods has grown, people have become more wary of alt milks, which typically contain additives, Amy Bentley, a professor of food studies at NYU who specializes in the American diet, told BI. "Alt meat and alt milk don't want to be put in that category. They want to say, 'Hey, we're different.' But if you read those ingredient labels of some of those alt products, they are very, very ultra processed," she said. This has been dairy's gain: "The pendulum has swung back," Andrea Hernández, the author of the food trends newsletter Snaxshot, told BI. "Milk was the original functional drink," Hernández said, "and it's become culturally cool again." "Consumers are still looking for simple ingredients and naturalness," Altobelli said. And traditional dairy products, like unflavored yogurts and cottage cheese, as well as more innovative ones like Fairlife, fit the bill. The cult status of raw dairy in a MAHA world Dairy products, including raw milk, have become part of a cultural conversation in the past year or so. Fans of raw milk say it contains more beneficial microbes than pasteurized milk and can protect against allergies and asthma. Food scientists, however, argue that the ostensible benefits of raw milk are outweighed on a population level by the risk of catching bird flu or being poisoned by E. coli. Raw milk, along with beef tallow and butter, has also become synonymous with the "make America healthy again," or MAHA, movement. Its spearhead, Robert F. Kennedy Jr, the US Health Secretary, said in June 2024 that he only drinks raw milk and, before he was appointed, criticized what he called the FDA's "aggressive suppression" of raw milk, which he said on X in October 2024 "advances human health." In late May, he took shots of the stuff in the White House on a podcast. Federal law prohibits the sale of raw milk across state lines, but individual state laws, not the FDA, dictate whether it can be sold within that state. Raw milk enthusiasts include people across the political and cultural spectrum. Republican congresswoman Marjorie Taylor Greene posted "Raw Milk does a body good" on X in October 2024. Gwyneth Paltrow, an early adopter of wellness culture, said she adds raw milk creamer to her coffee every morning. And "tradwife" influencer and dairy farmer Hannah Neeleman, who posts as "Ballerina Farm" online, was featured milking one of her cows on the cover of the conservative women's magazine Evie in November, emblazoned with the words " The New American Dream." Hernández said there is a "romanticization of a dairy farm or a farmer's life." "It's become trendy to be able to say, 'Oh, I got this $20 raw milk jug at Erewhon,'" the Los Angeles-based health food store known for its $20 smoothies, she said. The next era for dairy: exotic flavors with health benefits People may want their meals to be nutritious, but that doesn't mean they're willing to compromise on taste. On top of wellness, consumers, and Gen Z in particular, are looking for "unusual flavors as they seek new and unique experiences," according to branding consultancy and market research agency VML's Future 100: 2025 trends report. One in four of us want "interesting and exotic global flavor combinations," the report said. If the offerings at Natural Products Expo West, a prolific trade show for organic, sustainable food and beverage products, which took place in California in March, are any indication, brands are meeting the moment. Attendees could try ashwagandha -infused or Aleppo chile-flavored ghee, pineapple cottage cheese, and reduced-sugar chai tea-flavored yogurt. Alec's, an organic ice cream brand that displayed at the trade show, launched their Culture Cup, a 4 fl oz cup of ice cream with added pre- and probiotics, in April with flavors including chocolate-covered strawberry and dark chocolate honeycomb. All Things Butter, a company founded by the British chef Thomas Straker in 2023, has also gained traction for its flavored butters. Current products include cinnamon bun butter, chocolate butter, and smoked paprika butter. Unlike traditional butter packaging, its butter sticks come in colorful foil adorned with anthropomorphic cartoon cows. It was the first "very yassified, very millennial looking" dairy brand Hernández noticed, but she's certain we'll see many more.
